Gene · 7994
Papers1,720
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,720
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lactylation of METTL16 promotes cuproptosis via m6A-modification on FDX1 mRNA in gastric cancer. | Nat Commun | 2023 | 37863889 | PubTator, text mining | PubMed |
| HATS off to KAT6A/B inhibitors: A new way to target estrogen-receptor-positive breast cancer. | Cell Chem Biol | 2023 | 37863030 | PubTator, text mining | PubMed |
| KAT6A mutations in Arboleda-Tham syndrome drive epigenetic regulation of posterior HOXC cluster. | Hum Genet | 2023 | 37861717 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Investigation of the effects of phthalates on in vitro thyroid models with RNA-Seq and ATAC-Seq. | Front Endocrinol (Lausanne) | 2023 | 37810885 | PubTator, text mining | PubMed |
| Histone regulator KAT2A acts as a potential biomarker related to tumor microenvironment and prognosis of diffuse large B cell lymphoma. | BMC Cancer | 2023 | 37789275 | PubTator, text mining | PubMed |
| Repurposing disulfiram, an alcohol-abuse drug, in neuroblastoma causes KAT2A downregulation and in vivo activity with a water/oil emulsion. | Sci Rep | 2023 | 37777587 | PubTator, text mining | PubMed |
| TRIM25 targets p300 for degradation. | Life Sci Alliance | 2023 | 37770115 | PubTator, text mining | PubMed |
| The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML). | Cancers (Basel) | 2023 | 37760523 | PubTator, text mining | PubMed |
| The Lipid Metabolism as Target and Modulator of BOLD-100 Anticancer Activity: Crosstalk with Histone Acetylation. | Adv Sci (Weinh) | 2023 | 37752764 | PubTator, text mining | PubMed |
| Genomic Variations in Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma. | Cureus | 2023 | 37745740 | PubTator, text mining | PubMed |
| Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors. | ACS Chem Biol | 2023 | 37737090 | PubTator, text mining | PubMed |
| A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors. | Commun Biol | 2023 | 37723198 | PubTator, text mining | PubMed |
| Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours. | Int J Mol Sci | 2023 | 37686260 | PubTator, text mining | PubMed |
| Structural Variations Contribute to the Genetic Etiology of Autism Spectrum Disorder and Language Impairments. | Int J Mol Sci | 2023 | 37686052 | PubTator, text mining | PubMed |
| SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications. | Diagnostics (Basel) | 2023 | 37685308 | PubTator, text mining | PubMed |
| Review on the protective activity of osthole against the pathogenesis of osteoporosis. | Front Pharmacol | 2023 | 37680712 | PubTator, text mining | PubMed |
| Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia. | Blood Cancer J | 2023 | 37673866 | PubTator, text mining | PubMed |
| Targeting reversible post-translational modifications with PROTACs: a focus on enzymes modifying protein lysine and arginine residues. | J Enzyme Inhib Med Chem | 2023 | 37667522 | PubTator, text mining | PubMed |
| NMR structure verifies the eponymous zinc finger domain of transcription factor ZNF750. | J Struct Biol X | 2023 | 37655311 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7994/papers?page=9